Congestive Heart Failure News and Research

RSS
Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.
Hormone therapy may be hazardous in men with pre-existing heart conditions

Hormone therapy may be hazardous in men with pre-existing heart conditions

Key risk factors for death, transplantation in children with dilated cardiomyopathy

Key risk factors for death, transplantation in children with dilated cardiomyopathy

Symposium papers highlight role of oxidative stress in cardiovascular disease

Symposium papers highlight role of oxidative stress in cardiovascular disease

Rats, fish oil and beetroot juice could lead to health breakthroughs for aging populations

Rats, fish oil and beetroot juice could lead to health breakthroughs for aging populations

Montifiore's surgeons receive certification training for implanting total artificial heart

Montifiore's surgeons receive certification training for implanting total artificial heart

AMAG enters definitive merger agreement with Allos Therapeutics

AMAG enters definitive merger agreement with Allos Therapeutics

Two existing clinical stage clients expand development activities with Progenitor Cell Therapy

Two existing clinical stage clients expand development activities with Progenitor Cell Therapy

Patients with pulmonary hypertension more likely to have complications after bilateral TKA

Patients with pulmonary hypertension more likely to have complications after bilateral TKA

CLEOPATRA Phase III study on HER2-positive mBC meets primary endpoint

CLEOPATRA Phase III study on HER2-positive mBC meets primary endpoint

NeoStem to acquire Amorcyte

NeoStem to acquire Amorcyte

Research roundup: Rural hospitals have poorer quality; Cost-effective migraine relief; Doctors still take Medicare

Research roundup: Rural hospitals have poorer quality; Cost-effective migraine relief; Doctors still take Medicare

Critical access hospitals provide lower quality of care

Critical access hospitals provide lower quality of care

Sorbent expands $36M Series B financing

Sorbent expands $36M Series B financing

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

Two-pronged 'hybrid' procedure for treatment of atrial fibrillation

Two-pronged 'hybrid' procedure for treatment of atrial fibrillation

Expert addresses need to improve risk stratification of heart failure patients eligible for ICD or CRT-D

Expert addresses need to improve risk stratification of heart failure patients eligible for ICD or CRT-D

New data from JANUMET clinical study on type 2 diabetes presented at ADA 2011

New data from JANUMET clinical study on type 2 diabetes presented at ADA 2011

Anticholinergic medications linked to risk of cognitive impairment, death in older population

Anticholinergic medications linked to risk of cognitive impairment, death in older population

Pycnogenol, CoQ10 combination boost heart function

Pycnogenol, CoQ10 combination boost heart function

Study: Abdominal debrancing with aortic stent grafts linked to high early mortality

Study: Abdominal debrancing with aortic stent grafts linked to high early mortality

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.